Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck
15/02/2024
Important safety information on Varilrix in Mauritius (November 2020)
4/11/2020
Important safety information on Varilrix in Mauritius (January 2021)
21/01/2021
Important safety information on Resorcinol in Mauritius
23/02/2022
Important safety information on Cephalosporins in Mauritius (Safety Notification_Cephalosporins and risk of seizure)
01/03/2023
Important safety information on Cephalosporins in Mauritius (Safety Notification_Cephalosporins and risk of neurotoxicity)
07/03/2023
Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Mauritius
09/09/2023
Important safety information on Paroxetine in Mauritius (Safety Notification_EMA communication issued relating to Paroxetine label update)
27-10-2023
Important safety information on Topical Corticosteroids containing products in Mauritius
15-11-2023
Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe communication regarding labelling updates
19/12/2023
Important safety information on Zanamivir containing products - Precautions for prescribing and administering flu medications (zanamivir)
26/12/2023
Important safety information on Paroxetine containing products - Modifications of the information of medicines authorized by national procedure that contain Paroxetine
27/12/2023
This site is intended only for healthcare professionals. By clicking the button “I am a healthcare professional” you confirm that you are a member of the medical/dental/pharmacy/nursing professions and/or you are any other person who, in the course of the employment and delivery of patient care, may prescribe, recommend, purchase, administer, supply (or influence the supply) of medicines.
